Recent Company News

• 12:09 PM ET Oct 15, 2025
  

  Adocia reports Q3 revenue €0.4M vs year-ago €0.0M (€10.80, 0.00)

• 04:17 AM ET Jul 25, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 03:52 AM ET Oct 15, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (86 total)

• 02:51 AM ET Oct 15, 2025
  

  Adocia and Tonghua Dongbao announce positive topline results of Phase 3 trial on BioChaperone Lispro (THDB0206 injection) in people with T1D (€10.02, 0.00)

• 04:15 AM ET Oct 14, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (54 total)

• 12:04 PM ET Sep 25, 2025
  

  Adocia reports H1 net income (€9.3M) vs FactSet (€8.7M) [1 est] (€7.63, 0.00)

• 12:03 PM ET Sep 03, 2025
  

  Adocia announces oral presentations on AdoShell and BioChaperone at EASD, ESB and PODD 2025 Annual Meetings (€8.19, 0.00)

• 02:54 AM ET Jul 25, 2025
  

  Adocia, Tonghua Dongbao announce positive topline results of Phase 3 clinical trial on ultra-rapid insulin BioChaperone Lispro (THDB0206 injection) in people with Type 2 diabetes (€5.31, 0.00)